Edward Lang
Corporate Officer/Principal presso GYROSCOPE THERAPEUTICS HOLDINGS PLC
Posizioni attive di Edward Lang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Corporate Officer/Principal | 01/06/2019 | - |
Storia della carriera di Edward Lang
Precedenti posizioni note di Edward Lang
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/12/2017 | 01/06/2018 |
Formazione di Edward Lang
| LaSalle University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Regno Unito | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Edward Lang
- Esperienza
